Home
Products
Learn
About
Pricing
Log In
Back
IXC
Asset Logo

Invex Therapeutics Ltd

πŸ‡¦πŸ‡Ί ASX

πŸ“¦ LOGISTICS

Compare
Add to watchlist
πŸ‘‘ Overview

πŸ“ˆ Performance

πŸ’΅ Cost

πŸ€“ Advanced

πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ Community

πŸ“ˆ

-18.73%
Annual Growth

5 years average annual capital growth

πŸ’΅

$ 500
Minimum Order

Due to regulatory requirements

🌏

2
Pearlers Invested

Since January 2020

πŸ‘‘ Overview

Key information
πŸ”Ž Fund Overview

Invex Therapeutics Ltd. is a biopharmaceutical company, which engages in the research and development of treatment for neurological conditions resulting from raised intracranial pressure. The company is headquartered in Perth, Western Australia. The company went IPO on 2019-07-05. The firm is focused on focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure (ICP) including traumatic brain injury (TBI), stroke and hydrocephalus. In addition, the Company has generated early-stage data on the use of Exenatide in the treatment of glaucoma, through the lowering of intraocular pressure in the eye. Presendin is the Company’s filed (and granted) trademark name for reformulated Exenatide. The firm is focused on managing the close out of the Phase III Idiopathic Intracranial Hypertension (IIH) EVOLVE clinical trial and explore new potential applications for Exenatide in TBI and other neurological disorders with raised ICP, consistent with its patents.

πŸ“ˆ Performance

Price History

-76.75%

1M

1Y

All Time

Graph

Table

Unsure how much or often to invest?
πŸ—“οΈ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out β†’
πŸ’΅ Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out β†’
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out β†’

πŸ’΅ Costs

πŸ’΅

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

πŸ’Ό

N/A
Management Fee

Included in unit price, not charged by Pearler

πŸ’Έ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πŸ’Έ Net fee calculator

πŸ€“ Advanced information

Technical Info

πŸ’° Price*

$0.09

*Price may be up to 24 hours old

πŸ‘©β€πŸ‘©β€πŸ‘¦ Community Insights

How our community is investing

🌏 Pearlers invested in IXC

2

πŸ“Š Total Capital Earnings

N/A

πŸ”ƒ Average investment frequency

44 weeks

πŸ’΅ Average investment amount

$355

⏰ Last time a customer invested in IXC

768 days
IXC investor breakdown
πŸ’΅ Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

50%

Less than 50k

50%
πŸ‘Ά Age of investors

18 - 25

26 - 34

35 - 90

100%
πŸ™‹ Legal gender of investors

Female

Male

100%

Pearlers who invest in IXC also invest in...

Global X Battery Tech & Lithium ETF

ACDC

ACDC.AX was created on 2018-08-30 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the Solactive Battery ValueChain Index (the Index).

πŸ™Œ Performance (5Yr p.a)

11.32%

πŸ“Š Share price

$86.13 AUD

🌏 GLOBAL

πŸ›οΈ CONSUMER

🏭 INDUSTRIALS

πŸ“ˆ HIGH PRICE GROWTH

Find Out More

VTS.AX was created on 2009-05-12 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard U.S. Total Market Shares Index ETF seeks to track the performance of the CRSP US Total Market Index, providing investors with exposure to a broadly diversified collection of securities that, in the aggregate, approximates the full index in terms of key characteristics.

πŸ™Œ Performance (5Yr p.a)

19.72%

πŸ“Š Share price

$451.78 AUD

πŸ‡ΊπŸ‡Έ UNITED STATES

πŸ€– TECHNOLOGY

⛳️ DIVERSIFIED

πŸ“ˆ HIGH PRICE GROWTH

VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

πŸ™Œ Performance (5Yr p.a)

6.15%

πŸ“Š Share price

$69.63 AUD

⛳️ DIVERSIFIED

🌏 GLOBAL

VGE.AX was created on 2013-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Seeks to track the return of the FTSE Emerging Markets All Cap China A Inclusion Index in Australian dollars, before taking into account fees, expenses and tax.

πŸ™Œ Performance (5Yr p.a)

5.87%

πŸ“Š Share price

$81.65 AUD

⛳️ DIVERSIFIED

🌏 GLOBAL

Arafura Rare Earths Ltd. engages in the exploration and development of mineral resource properties. The company is headquartered in Perth, Western Australia. The company went IPO on 2003-11-05. The firm produces rare earth products from the Nolans Project. The Nolans Project consists of a mine, process plant, including beneficiation, extraction and separation plants, and related infrastructure to be constructed and located at the Nolans site, approximately 135 kilometers north of Alice Springs in Australia's Northern Territory. Its rare earth products are Neodymium-Praseodymium (NdPr) oxide, and Mixed middle-heavy rare earths (SEG/HRE) oxide. NdPr oxide is the Company's flagship product, which is used by magnet and magnet alloy customers. The Company’s primary products from the Nolans project are rare earths, which are used in catalytic converters in automobiles, consumer electronics, energy efficiency lighting, optics, alloys, advanced ceramics and permanent magnets that enable e-mobility and renewable energy applications.

πŸ™Œ Performance (5Yr p.a)

24.87%

πŸ“Š Share price

$0.17 AUD

πŸ“ˆ HIGH PRICE GROWTH

⛏️ MINING

Want more shares? Try these...

IXI.AX was created on 2006-09-12 by iShares. The fund's investment portfolio concentrates primarily on consumer staples equity. The fund aims to provide investors with the performance of the S&P Global 1200 Consumer Staples Sector Index, before fees and expenses. The index is designed to measure the performance of global consumer staples companies and may include large-, mid- or smallcapitalisation stocks.

πŸ™Œ Performance (5Yr p.a)

7.11%

πŸ“Š Share price

$102.70 AUD

🌏 GLOBAL

IWLD.AX was created on 2016-04-22 by iShares. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of global, developed market large, mid and smallcapitalisation companies

πŸ™Œ Performance (5Yr p.a)

14.21%

πŸ“Š Share price

$61.63 AUD

🌏 GLOBAL

πŸ€– TECHNOLOGY

⛳️ DIVERSIFIED

🌳 ENVIRONMENTAL

πŸ“ˆ HIGH PRICE GROWTH

Compare
Add to watchlist